Light enhanced cytotoxicity and antitumoral effect of a ruthenium-based photosensitizer inspired from natural alkaloids

In this work, we report on the synthesis and properties of a new sensitizer for photodynamic therapy applications, constituted by a ruthenium(ii) complex (1) featuring a ligand inspired from natural isoquinoline alkaloids. The spectroscopic analysis revealed that 1 is characterized by an intense red emission (<i>λ</i> <sub>em</sub> = 620 nm, <i>Φ</i> = 0.17) when excited at 550 nm, a low energy radiation warranting for a safe therapeutic approach. The phototoxicity of 1 on human breast cancer (Hs578T) and melanoma (A375) cell lines was assessed after irradiation using a LED lamp (525 nm, total fluence 10 J cm<sup>-2</sup>). <i>In vitro</i> biological assays indicated that the cytotoxicity of 1 was significantly enhanced by light reaching IC<sub>50</sub> values below the micromolar threshold. The cell damage induced by 1 proved to be strictly connected with the overproduction of reactive oxygen species (ROS) responsible for mitochondrial dysfunction leading to the activation of caspases and then to apoptosis, and for DNA photocleavage leading to cell cycle arrest.

Authors

Institutions

Publication Details

Journal
RSC Medicinal Chemistry
Published
2024-10-25
DOI
https://doi.org/10.1039/d4md00600c
Citations
3
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
1.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Light enhanced cytotoxicity and antitumoral effect of a ruthenium-based photosensitizer inspired from natural alkaloids

Maria Laura Alfieri, Giuseppina Luciani, Barbara Carrese, Paola Manini et al.
3 citations
RSC Medicinal Chemistry
Photodynamic Therapy Research Studies
1.26
article

Light enhanced cytotoxicity and antitumoral effect of a ruthenium-based photosensitizer inspired from natural alkaloids

Maria Laura Alfieri, Giuseppina Luciani, Barbara Carrese, Paola Manini, Brigida Silvestri, Gennaro Sanità, Gaetano Calı̀, Susan Mohammadi, Valentina Mele, Annalisa Lamberti, Sebastiano Marra, Serena Damian
article en
3 citations

Abstract

In this work, we report on the synthesis and properties of a new sensitizer for photodynamic therapy applications, constituted by a ruthenium(ii) complex (1) featuring a ligand inspired from natural isoquinoline alkaloids. The spectroscopic analysis revealed that 1 is characterized by an intense red emission (<i>λ</i> <sub>em</sub> = 620 nm, <i>Φ</i> = 0.17) when excited at 550 nm, a low energy radiation warranting for a safe therapeutic approach. The phototoxicity of 1 on human breast cancer (Hs578T) and melanoma (A375) cell lines was assessed after irradiation using a LED lamp (525 nm, total fluence 10 J cm<sup>-2</sup>). <i>In vitro</i> biological assays indicated that the cytotoxicity of 1 was significantly enhanced by light reaching IC<sub>50</sub> values below the micromolar threshold. The cell damage induced by 1 proved to be strictly connected with the overproduction of reactive oxygen species (ROS) responsible for mitochondrial dysfunction leading to the activation of caspases and then to apoptosis, and for DNA photocleavage leading to cell cycle arrest.

RSC Medicinal ChemistryVol. 16(2)
Institute for Experimental Endocrinology and Oncology (IT), Scuola Superiore Meridionale (IT), National Research Council (IT), University of Naples Federico II (IT)
European Regional Development Fund
Openalex Percentile: Top 18%
Photodynamic Therapy Research Studies
1.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.